September 19, 2022 by Katy Rauen, Kate Maheu and DJ McKerr
DJ McKerr, Kate Maheu, Kathryn Rauen, Kearney
Opinion, Pharmacy, September 19, 2022

As health care players race to deliver on the promise of integrated care, they’re assembling capabilities through M&A and changing the way the ecosystem works. While community pharmacies continue to publicly demonstrate commitment to evolving their offerings, they will need to demonstrate their value in different ways as influencers in the health ecosystem evolve. For
April 29, 2021 by Todd Huseby, Katy Rauen and Laura Bowen
Katy Rauen, Laura Bowen, The U.S. prescription drug market has reached half a trillion dollars, Todd Huseby is a partner at Kearney. He can be contacted at [email protected]
April 26, 2021, Opinion

The U.S. prescription drug market has reached half a trillion dollars, much of it dominated by large pharmacy service providers. But with a pie this big, it’s little wonder that new players are looking to horn in on the action — in particular “digital native” start-ups that give customers the direct consumer-centric relationship and flexible
November 18, 2020 by Todd Huseby, Katy Rauen and Brendan See
Amazon, Kearney
Featured Articles, Leading Headlines, Pharmacy

Ever since its launch as an online bookstore 25 years ago, Amazon has ignored traditional economics as it solves customer challenges in new ways — raising expectations and forcing competitors to do better in the process. Over the past few years, Amazon has ramped up the number of experiments, acquisitions and offerings across the health
May 10, 2018 by Chris Paddison and Katy Rauen
Amazon, drug retailing
Opinion

Who knew that the ancient Greek philosopher Heraclitus would sum up Amazon.com’s influence on our modern health care industry so well? “The only constant is change,” he is said to have uttered, along with “You cannot step twice into the same river.” That river now is Amazon, a mighty one that has shifted to run
July 3, 2017 by Rodey Wing, Ella Berlyand, Katy Rauen and Chain Drug Review
A.T. Kearney, accredited URAC pharmacy, Ella Berlyand, Katy Rauen, limited-distribution drugs, Rodey Wing, specialty pharmacy, specialty pharmacy industry
2017, Issue 07-03-2017, Issues, Opinion

In recent years, the specialty pharmacy industry has been defined by rapid growth with considerable entry from new participants. Factors driving growth include an increase of therapies introduced into the pharmacy benefit class rather than through the medical benefit, a growing number of patients receiving treatment for a wider range of conditions, price inflation caused